Surgical Antimicrobial Prophylaxis Best Practices for Antibiotic Stewardship and Resistance Prevention

A clean incision can still become infected if bacterial contamination meets the right host and procedural conditions. Surgical site infections remain among the most consequential healthcare-associated infections because they prolong admission, increase reoperation risk, add antimicrobial exposure, and raise costs. A single prophylactic dose, given at the right time and aimed at the right organisms, can prevent harm. The same antibiotic, given too broadly or for too long, can drive resistance and adverse events.

That is the central tension in Surgical Antimicrobial Prophylaxis: prevent surgical site infection without converting prophylaxis into unnecessary treatment.

This article summarises current best practice for perioperative antibiotic use, drawing on widely used principles from WHO, CDC, ASHP/IDSA/SIS/SHEA, NICE, and stewardship frameworks relevant to Indian hospitals. It is intended for clinical education and protocol development, not as a substitute for local policy, microbiology advice, or patient-specific judgement.

Effective prophylaxis starts before incision, with preparation, timing, and clear intent.

Why antimicrobial prophylaxis matters in surgery

Surgical antimicrobial prophylaxis aims to reduce the microbial burden at the operative site during the short period when contamination can lead to infection. It is not meant to sterilise tissues, treat established infection, or compensate for breaks in surgical technique.

The benefit is strongest when antibiotics are used alongside established infection prevention measures:

• appropriate skin antisepsis

• sterile technique

• normothermia

• glycaemic control

• safe hair removal with clippers when needed

• good haemostasis and tissue handling

• appropriate operating room discipline

• timely removal of invasive devices

  
  

The rationale is microbiological and time-sensitive. During incision and tissue handling, endogenous flora from the skin, mucosa, bowel, genitourinary tract, or respiratory tract may enter the wound. Prophylaxis works best when therapeutic antibiotic levels are present in serum and tissues at the time of incision and maintained through the period of exposure.

Evidence-based guidelines consistently support prophylaxis for procedures where the baseline risk of infection is significant, where prosthetic material is implanted, or where an SSI would carry high morbidity. By contrast, low-risk clean procedures without implant placement often do not need prophylaxis.

Stewardship principles that apply in the operating theatre

Antibiotic stewardship in surgery is not about withholding antibiotics when indicated. It is about using them with precision.

Use prophylaxis only when the expected benefit is clear

Not every incision requires antibiotics. The decision should consider:

• wound classification

• expected organisms

• presence of implants

• patient risk factors

• duration and complexity of surgery

• consequences of infection

  
  

Clean procedures without prosthetic material, such as minor dermatological excisions in immunocompetent patients, often have a low infection risk. Clean procedures with implants, such as joint replacement or cardiac valve surgery, usually require prophylaxis because infection around foreign material can be devastating.

Clean-contaminated procedures, such as colorectal, biliary, upper gastrointestinal, gynaecological, and urological procedures entering colonised tracts, generally need prophylaxis targeted to expected flora.

Choose the narrowest effective agent

The best prophylactic antibiotic is not the broadest one. It is the one that reliably covers likely organisms for that operation, has good tissue penetration, is safe, is affordable, and is supported by local susceptibility patterns.

For many clean surgeries, cefazolin remains a standard option because it covers methicillin-susceptible Staphylococcus aureus and streptococci well. It also has a long track record in orthopaedic, cardiac, vascular, and many general surgical procedures.

Broader gram-negative and anaerobic cover is reserved for operations where those organisms are likely, such as colorectal surgery. Routine escalation to piperacillin-tazobactam, carbapenems, or prolonged combinations is rarely justified for prophylaxis alone and can undermine stewardship.

Keep duration short

For most operations, a single pre-incision dose is enough. If surgery is prolonged or blood loss is substantial, intraoperative redosing may be needed. Postoperative continuation beyond wound closure usually offers no added benefit for many procedures and increases harm.

WHO guidance on SSI prevention recommends against continuing prophylactic antibiotics after completion of surgery in routine circumstances. Many hospital protocols align with the principle that prophylaxis should stop within 24 hours, and often at closure, unless there is a separate therapeutic indication.

Separate prophylaxis from treatment

A contaminated traumatic wound, perforated viscus, pus encountered intraoperatively, or established infection shifts the intent from prophylaxis to treatment. In those cases, antibiotics should be selected, dosed, cultured, and reviewed as therapeutic therapy, not labelled as “prophylaxis” and continued without reassessment.

Selecting the right antibiotic for the right procedure

Antibiotic choice should be guided by expected pathogens at the operative site.

For clean skin-incision procedures, the main concern is skin flora, particularly S. aureus and coagulase-negative staphylococci. For bowel surgery, gram-negative bacilli and anaerobes are key. For urological procedures, gram-negative urinary pathogens matter, and local resistance patterns are especially important.

Hospitals should maintain procedure-specific protocols based on national guidance, local antibiograms, and formulary constraints. In India, this is particularly relevant because antimicrobial resistance patterns vary widely across regions and institutions.

Procedure-specific antibiotic choice should be standardised, documented, and easy to verify.

Surgical procedure or category	Common prophylaxis approach	Rationale
Total hip or knee arthroplasty	Cefazolin, or alternative if severe beta-lactam allergy or MRSA risk	Prosthetic joint infection has high morbidity and may require revision surgery
Cardiac surgery with sternotomy	Cefazolin or cefuroxime in many protocols, with MRSA-directed cover when indicated	Skin flora can cause mediastinitis, bloodstream infection, or prosthetic infection
Vascular graft surgery	Cefazolin in many settings	Infection involving graft material is difficult to eradicate
Caesarean section	Cefazolin before skin incision in most protocols	Reduces endometritis and wound infection while limiting neonatal and maternal exposure
Colorectal surgery	Cefazolin plus metronidazole, cefoxitin, or ceftriaxone plus metronidazole, depending on protocol	Gram-negative bacilli and anaerobes are expected
Appendicectomy for non-perforated appendicitis	Gram-negative and anaerobic cover	Involves enteric organisms, but duration should remain short if no perforation
Biliary tract surgery in high-risk cases	Gram-negative cover based on local policy	Risk rises with obstruction, acute cholecystitis, older age, diabetes, or instrumentation
Transurethral resection and selected urological procedures	Agent based on urine culture and local resistance	Urinary tract flora and instrumentation increase bacteraemia and UTI risk
Neurosurgery with craniotomy or shunt placement	Cefazolin in many protocols	Skin flora can infect deep spaces or implanted devices
Breast surgery with implant or reconstruction	Cefazolin in many protocols	Implant-associated infection can require removal

This table is not a universal prescription. Local protocols should specify first-line and alternative agents, renal dosing guidance where relevant, redosing intervals, and allergy pathways.

Timing and dosage are as important as drug choice

The right antibiotic can fail if given at the wrong time. Prophylaxis should achieve adequate tissue concentration before the first incision.

Start within the correct pre-incision window

Most intravenous prophylactic antibiotics should be administered within 60 minutes before incision. Agents requiring longer infusion times, such as vancomycin or fluoroquinolones, are usually started within 120 minutes before incision to ensure completion before the cut.

This timing standard appears across major surgical prophylaxis guidance because tissue levels at incision correlate with effectiveness. Giving the dose after incision weakens the preventive effect. Giving it too early may allow levels to fall during surgery.

Use weight-based dosing where recommended

Underdosing can lead to subtherapeutic tissue levels, especially in patients with high body weight. Common adult cefazolin prophylaxis protocols use:

• 2 g IV for many adults

• 3 g IV for patients above 120 kg in many guidelines

  
  

Paediatric dosing and dosing in renal dysfunction should follow institutional policy. For single-dose prophylaxis, renal adjustment may not be needed for some agents, but this should be protocolised rather than improvised.

Redose during long operations or major blood loss

Intraoperative redosing is needed when the operation exceeds roughly two half-lives of the drug or when there is major blood loss. For cefazolin, many protocols redose every 4 hours during prolonged procedures.

Redosing is especially relevant in:

• complex abdominal operations

• revision arthroplasty

• prolonged cardiac or vascular surgery

• major trauma surgery

• cases with high-volume fluid shifts or blood loss

  
  

The anaesthesia record should include the dose, time, and any redose. Missing documentation often leads to unnecessary postoperative continuation because teams cannot confirm that intraoperative prophylaxis was adequate.

Procedures that require prophylaxis and why

Orthopaedic implant surgery

Joint replacement, spinal instrumentation, fracture fixation with hardware, and other implant procedures usually require prophylaxis. The bacterial load needed to infect a prosthesis is lower than in native tissue, and biofilm formation makes infection difficult to treat.

Skin flora dominate early infections. Cefazolin is commonly appropriate unless there is severe beta-lactam allergy or a specific MRSA indication. Routine vancomycin for every patient is poor stewardship, particularly where MRSA prevalence does not justify it.

Caesarean section and gynaecological surgery

For caesarean section, pre-incision prophylaxis reduces maternal infectious morbidity, including endometritis and wound infection. Modern practice favours administration before skin incision rather than after cord clamping.

Hysterectomy and selected vaginal or laparoscopic gynaecological procedures also require prophylaxis because vaginal flora and anaerobes may contaminate the operative field.

Colorectal and abdominal surgery

Colorectal surgery has a high microbial challenge due to dense enteric flora. Prophylaxis must cover gram-negative organisms and anaerobes. Mechanical bowel preparation with oral antibiotics may be used in some colorectal pathways, depending on local policy and patient factors.

For upper gastrointestinal, hepatobiliary, and pancreatic surgery, prophylaxis depends on the specific operation and risk factors. Obstruction, altered biliary anatomy, stents, previous instrumentation, and jaundice can shift the likely pathogens and resistance profile.

Operations involving bowel or biliary contamination need cover that matches expected organisms.

Cardiac and vascular surgery

Sternotomy, valve replacement, cardiac device procedures, and vascular graft placement need prophylaxis because infection can involve mediastinal tissue, prosthetic valves, grafts, or implanted devices. The consequences include reoperation, sepsis, and prolonged antibiotics.

Glycaemic management, nasal decolonisation strategies in selected patients, and meticulous skin antisepsis can complement antibiotic prophylaxis.

Urological surgery

Urological prophylaxis should be selective and microbiology-led. Preoperative urine culture is important when infection or colonisation is suspected. If bacteriuria is present before a mucosa-breaching procedure, targeted therapy may be needed rather than standard prophylaxis.

Local resistance matters because fluoroquinolone resistance among urinary pathogens is common in many settings. A protocol that worked a decade ago may no longer be reliable.

Managing allergies, MRSA risk, and special populations

Allergy labels deserve scrutiny. Many patients who report “penicillin allergy” do not have true IgE-mediated allergy. Avoiding beta-lactams unnecessarily may push clinicians toward clindamycin or vancomycin, which can be less effective for some procedures and may carry additional risks.

A practical pathway should distinguish:

• non-allergic adverse effects, such as nausea

• remote childhood rash without severe features

• immediate urticaria, bronchospasm, or anaphylaxis

• severe cutaneous adverse reactions, such as Stevens-Johnson syndrome

  
  

For MRSA colonisation or high MRSA risk, vancomycin may be added or substituted depending on the procedure and local policy. Vancomycin alone is not ideal for gram-negative or anaerobic risk, and it should not become routine prophylaxis for all clean surgery.

Special populations need planned dosing rather than last-minute changes:

• obesity

• renal impairment

• pregnancy

• paediatric patients

• immunosuppression

• patients already receiving antibiotics

  
  

If a patient is already on an antibiotic that covers expected organisms, an additional prophylactic dose may still be needed to ensure correct timing and tissue levels. If the existing antibiotic does not cover likely surgical pathogens, prophylaxis should be added according to the procedure.

The risks of overuse and inappropriate prophylaxis

Antibiotic harm is not theoretical. Unnecessary perioperative antibiotics increase the risk of adverse drug reactions, Clostridioides difficile infection, drug interactions, nephrotoxicity, and selection of resistant organisms.

Prolonged prophylaxis can also distort postoperative diagnosis. Fever after surgery may trigger more antibiotics if the patient is already receiving “cover”, even when the cause is atelectasis, haematoma, inflammation, thrombosis, transfusion reaction, or drug fever.

The resistance concern is especially relevant where broad-spectrum antibiotics are easy to start and hard to stop. Carbapenem use for routine prophylaxis, for example, can select carbapenem-resistant Enterobacterales. Repeated unnecessary vancomycin exposure may contribute to vancomycin-resistant enterococci and nephrotoxicity when combined with other renal stressors.

The stewardship question should be asked before every incision: does this patient need prophylaxis, and if yes, what is the narrowest effective dose at the correct time?

Practical stewardship steps for hospitals

Surgical prophylaxis improves when the process is built into theatre workflow rather than left to memory.

Effective systems usually include:

• procedure-specific antibiotic charts

• preoperative checklist prompts

• anaesthesia-led timing documentation

• automatic stop orders

• redosing reminders for long operations

• local antibiogram review

• periodic audit with feedback

• allergy assessment pathways

• review of postoperative continuation rates

  
  

A simple audit can reveal major gaps. Track whether prophylaxis was indicated, whether the correct agent was used, whether it was given within the recommended window, whether redosing occurred when needed, and whether antibiotics were stopped appropriately.

Hospitals can also monitor concordance by surgical unit and procedure type. Feedback should be specific. “Antibiotic use is high” is less useful than “cefazolin was continued beyond 24 hours in 48 of 60 elective arthroplasty cases last month despite no documented therapeutic indication.”

Timing failures are preventable when prophylaxis is built into theatre workflow.

Frequently asked questions

Is one dose of antibiotic really enough for many operations?

Yes, for many procedures. If the antibiotic reaches adequate tissue levels before incision and the operation is not prolonged, a single dose is often sufficient. Longer duration does not reliably reduce SSI risk in routine cases and increases antibiotic-related harm.

Should vancomycin be used routinely for implant surgery?

No. Vancomycin should be reserved for clear indications such as MRSA colonisation, high institutional MRSA risk, or severe beta-lactam allergy where local policy supports it. Routine use can miss gram-negative organisms and adds toxicity and resistance pressure.

What if the operation lasts longer than expected?

Redose according to the antibiotic’s redosing interval and intraoperative blood loss. Cefazolin is commonly redosed every 4 hours in prolonged procedures. Documentation should show the time of each dose.

Are postoperative antibiotics needed while drains are in place?

Routine continuation solely because a drain remains in place is not supported for most procedures. If there is no established infection or separate therapeutic indication, prophylaxis should usually stop as per protocol.

How should prophylaxis be handled when preoperative cultures are positive?

If the culture represents colonisation relevant to the procedure, prophylaxis may need adjustment. If it represents active infection, treat it as therapy. For urological procedures, urine culture results are especially important before mucosa-breaching operations.

The takeaway for safer surgical prophylaxis

Surgical antibiotic prophylaxis works when it is deliberate, narrow, timed, and short. The strongest practice is not the longest prescription. It is the dose that matches the operation, reaches the tissue before incision, is repeated only when pharmacology demands it, and stops when prophylaxis has done its job.

Good stewardship protects the patient on the table today and the patients who will need effective antibiotics tomorrow.